Problems existing in the CMO raw material medicine industry
Custom Synthesis, China is already one of the most export-competitive countries in the world, and it has a monopoly position in the export of traditional bulk CMO raw materials such as penicillin, paracetamol, vitamin products and so on, CMO.
The export situation in recent years also reflects the steady growth of the export volume of CMO APIs in China.
Although China’s chemical CMO raw materials in the production of some of these products have a definite comparative advantage, but we should also be soberly aware that the above products are some traditional old products, and some are still developed countries are unwilling to produce heavy pollution, low value-added products, many products are also being phased out of the danger of elimination.
But for the current international market of some high value-added products, high technical barriers, China has not much advantage to say. Even if some products in China can be produced, but since the accession to the WTO, intellectual property restrictions can not be produced.
Therefore, the prospect of chemical CMO in our country is still worrying, that is, in the long period of time, our country’s chemical pharmaceutical industry will be in a backward situation in CMO raw material medicine production.http://www.haihengpharma.com/problems-existing-in-the-cmo-raw-material-medicine-industry/News